About the Photodynamic Therapy Session
Photodynamic therapy (PDT) in ophthalmology harnesses light-activated photosensitizing agents to target abnormal blood vessels beneath the retina. It's a pivotal treatment for conditions like wet age-related macular degeneration (AMD) and specific diabetic eye diseases. PDT involves injecting a photosensitizing drug into the bloodstream, where it accumulates in problematic vessels. When exposed to a specific light wavelength, the drug activates, selectively damaging the abnormal vessels while preserving healthy tissue. This process helps reduce leakage and stabilize vision, crucially halting further deterioration in diseases such as wet AMD. While not a cure for vision loss, PDT effectively complements treatments like anti-VEGF injections, playing a pivotal role in managing sight-threatening retinal disorders with its precise and targeted approach.
Topics Covered in Photodynamic Therapy
Verteporfin
Subfoveal CNV
Polypoidal Choroidal Vasculopathy
Central Serous Chorioretinopathy
Choroidal Hemangioma
Anti-VEGF Combination
Related Scientific Sessions at IOC 2027
Why Attend the Photodynamic Therapy Conference 2027
Earn CPD Credit
Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.
Present Your Research
Oral and poster slots for original Photodynamic Therapy work, reviewed by the scientific committee.
Network Globally
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Publish & Get Indexed
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Learn from Keynotes
Plenary lectures from leading voices shaping Photodynamic Therapy research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join IOC 2027 for the Photodynamic Therapy track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Photodynamic Therapy Conference 2027 — FAQs
What is the Photodynamic Therapy track at IOC 2027?
The Photodynamic Therapy track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Photodynamic Therapy. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Photodynamic Therapy sessions?
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Photodynamic Therapy are all welcome — whether presenting or attending.
Can I present my research in the Photodynamic Therapy track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Photodynamic Therapy sessions?
Yes. IOC 2027 is a hybrid conference — attend the Photodynamic Therapy track in person in Singapore or join live online, with on-demand access afterward.
Join the IOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.